Simplex Trading’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-33,000
| Closed | -$9K | – | 10397 |
|
|
2023
Q2 | $9K | Sell |
33,000
-20,600
| -38% | -$145K | ﹤0.01% | 7548 |
|
|
2023
Q1 | $225K | Sell |
53,600
-27,300
| -34% | -$142K | ﹤0.01% | 4188 |
|
|
2022
Q4 | $486K | Buy |
80,900
+73,600
| +1,008% | +$402K | ﹤0.01% | 3181 |
|
|
2022
Q3 | $42K | Sell |
7,300
-8,900
| -55% | -$55.5K | ﹤0.01% | 6687 |
|
|
2022
Q2 | $96K | Buy |
16,200
+200
| +1% | +$1.02K | ﹤0.01% | 5619 |
|
|
2022
Q1 | $74K | Sell |
16,000
-11,400
| -42% | -$34K | ﹤0.01% | 6581 |
|
|
2021
Q4 | $67K | Sell |
27,400
-2,200
| -7% | -$5.38K | ﹤0.01% | 6848 |
|
|
2021
Q3 | $76K | Hold |
29,600
| – | – | ﹤0.01% | 7004 |
|
|
2021
Q2 | $74K | Buy |
29,600
+29,551
| +60,308% | +$70.9K | ﹤0.01% | 7160 |
|
|
2021
Q1 | $14K | Buy |
+49
| New | +$160 | ﹤0.01% | 7733 |
|
|
2020
Q4 | – | Sell |
-18
| Closed | -$3K | – | 9540 |
|
|
2020
Q3 | $3K | Sell |
18
-59
| -77% | -$75 | ﹤0.01% | 7374 |
|
|
2020
Q2 | $8K | Buy |
+77
| New | +$81 | ﹤0.01% | 6795 |
|
|
2020
Q1 | – | Sell |
-246
| Closed | -$38K | – | 8749 |
|
|
2019
Q4 | $38K | Buy |
246
+201
| +447% | +$190 | ﹤0.01% | 5462 |
|
|
2019
Q3 | $3K | Sell |
45
-242
| -84% | -$185 | ﹤0.01% | 6877 |
|
|
2019
Q2 | $24K | Buy |
+287
| New | +$265 | ﹤0.01% | 5490 |
|
|
2019
Q1 | – | Sell |
-17
| Closed | -$1K | – | 8422 |
|
|
2018
Q4 | $1K | Buy |
17
+1
| +6% | +$2 | ﹤0.01% | 6874 |
|
|
2018
Q3 | $3K | Hold |
16
| – | – | ﹤0.01% | 7036 |
|
|
2018
Q2 | $7K | Buy |
+16
| New | +$70 | ﹤0.01% | 6586 |
|
|
2017
Q2 | – | Sell |
-1,100
| Closed | -$2K | – | 7418 |
|
|
2017
Q1 | $2K | Buy |
1,100
+980
| +817% | +$4.52K | ﹤0.01% | 5484 |
|
|
2016
Q4 | $17K | Buy |
+120
| New | +$498 | ﹤0.01% | 3221 |
|
|
2015
Q1 | – | Sell |
-6
| Closed | -$1K | – | 6319 |
|
|
2014
Q4 | $1K | Buy |
+6
| New | +$139 | ﹤0.01% | 4552 |
|
Simplex Trading's CTIC Position: Q2 2023 in Review
Simplex Trading sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q2 2023, closing a stake of 14,801 shares — an estimated $104K sold.
Simplex Trading first reported a position in CTIC in Q1 2015 and held it in 18 quarters. The position peaked at $740K in Q1 2022. 2 funds tracked by Wall St. Rank hold CTIC as of Q2 2023.
- Simplex Trading reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q2 2023 after selling out during the quarter.
- Simplex Trading sold 14,801 CTI BioPharma Corp. (DE) Common Stock shares in Q2 2023, an estimated $104K.
- Simplex Trading first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q1 2015 and held it in 18 quarters.
- Simplex Trading's CTI BioPharma Corp. (DE) Common Stock position peaked at $740K in Q1 2022.
- 2 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q2 2023.
Based on Simplex Trading's 13F filing for Q2 2023, filed 4 Aug 2023.